Effet antitumoral des analogues de la somatostatine dans les tumeurs neuroendocrines digestives = Antiproliferative effect of somatostatin analogs in neuroendocrine tumorsDE MESTIER, Louis; HENTIC, Olivia; BRIXI, Hedia et al.Hépato-gastro & oncologie digestive. 2014, Vol 21, Num 10, pp 835-844, issn 2115-3310, 10 p.Article

Influence du lanréotide sur la concentration sérique de prolactine chez les patients atteints de tumeurs somato-lactotropes = Effect of lanreotide on prolactin level in patients with pituitary mixed tumorsWASKO, R; SAWICKA, J; STACHOWIAK, C et al.Annales d'endocrinologie. 2002, Vol 63, Num 6, pp 532-535, issn 0003-4266, 4 p., 1Article

Systematic review and meta-analysis of the role of somatostatin and its analogues in the treatment of enterocutaneous fistulaSTEVENS, Philip; FOULKES, Rhiannon E; HARTFORD-BEYNON, Jake S et al.European journal of gastroenterology & hepatology. 2011, Vol 23, Num 10, pp 912-922, issn 0954-691X, 11 p.Article

Prise en charge de l'acromégalie évolutive au cours de la grossesse = Management of acromegaly in pregnant womanBEN SALEM HACHMI, L; KAMMOUN, I; BOUZID, C et al.Annales d'endocrinologie. 2010, Vol 71, Num 1, pp 60-63, issn 0003-4266, 4 p.Article

Lanreotide in Metastatic Enteropancreatic Neuroendocrine TumorsCAPLIN, Martyn E; PAVEL, Marianne; RINDI, Guido et al.The New England journal of medicine. 2014, Vol 371, Num 3, pp 224-233, issn 0028-4793, 10 p.Article

Dose-dependent gastrointestinal effects of the somatostatin analog lanreotide in healthy volunteersDREWE, J; SIEBER, C. C; MOTTET, C et al.Clinical pharmacology and therapeutics. 1999, Vol 65, Num 4, pp 413-419, issn 0009-9236Article

Chemoprevention of hepatocellular carcinoma. Proof of concept in animal modelsBORBATH, I; STÄRKEL, P.Acta gastro-enterologica belgica (English ed.). 2011, Vol 74, Num 1, pp 34-44, issn 1784-3227, 11 p.Article

Positive octreotide scintigraphy and determination of lanreotide activity in paget's disease of bone associated with phosphate diabetes: a case reportVANDEMERGEL, X; BLOCKLET, D; DECAUX, G et al.Annales d'endocrinologie. 2004, Vol 65, Num 3, pp 201-204, issn 0003-4266, 4 p.Article

Effectiveness and tolerability of 3-year lanreotide Autogel® treatment in patients with acromegalyCARON, Philippe; COGNE, Muriel; RAINGEARD, Isabelle et al.Clinical endocrinology (Oxford. Print). 2006, Vol 64, Num 2, pp 209-214, issn 0300-0664, 6 p.Article

¹¹¹In- and ⁹⁰Y-DOTA-lanreotide: Results and implications of the MAURITIUS trialVIRGOLINI, Irene; BRITTON, Keith; BUSCOMBE, John et al.Seminars in nuclear medicine. 2002, Vol 32, Num 2, pp 148-155, issn 0001-2998Article

Lanreotide treatment of metastatic hepatocellular carcinoma resulting in partial regression and more than 3 years of progression-free survivalBORBATH, Ivan; LHOMMEL, Renaud; GUIOT, Yves et al.Acta gastro-enterologica belgica (English ed.). 2012, Vol 75, Num 2, pp 270-273, issn 1784-3227, 4 p.Article

Does first-line surgery still have its place in the treatment of acromegaly?CASTINETTI, F; MORANGE, I; DUBOIS, N et al.Annales d'endocrinologie. 2009, Vol 70, Num 2, pp 107-112, issn 0003-4266, 6 p.Article

Lanreotide autogel every 6 weeks compared with lanreotide microparticles every 3 weeks in patients with well differentiated neuroendocrine tumors : A phase III studyBAJETTA, Emilio; PROCOPIO, Giuseppe; DE BRAUD, Filippo et al.Cancer. 2006, Vol 107, Num 10, pp 2474-2481, issn 0008-543X, 8 p.Article

Mechanisms of Action and Resistance of Somatostatin Analogues for the Treatment of Hepatocellular Carcinoma : A Message Not Well TakenSAMONAKIS, Dimitrios N; NOTAS, George; CHRISTODOULAKIS, Nikolaos et al.Digestive diseases and sciences. 2008, Vol 53, Num 9, pp 2359-2365, issn 0163-2116, 7 p.Article

Randomized, Placebo-Controlled, Double-Blind Study of the Efficacy of Lanreotide 30 mg PR in the Treatment of Pancreatic and Enterocutaneous FistulaeGAYRAL, François; CAMPION, Jean-Pierre; REGIMBEAU, Jean-Marc et al.Annals of surgery. 2009, Vol 250, Num 6, pp 872-877, issn 0003-4932, 6 p.Article

Surgical debulking of pituitary macroadenomas causing acromegaly improves control by lanreotideKARAVITAKI, N; TURNER, H. E; ADAMS, C. B. T et al.Clinical endocrinology (Oxford. Print). 2008, Vol 68, Num 6, pp 970-975, issn 0300-0664, 6 p.Article

Associations of remission status and lanreotide treatment with quality of life in patients with treated acromegalyHUA, Shih-Che; YAN, Yuan-Horng; CHANG, Tien-Chun et al.European journal of endocrinology. 2006, Vol 155, Num 6, pp 831-837, issn 0804-4643, 7 p.Article

Lanreotide effect on splanchnic blood flow in healthy subjects: Effect of the rate of infusionSIEBER, Cornel C; BEGLINGER, Christoph; BART, Simone et al.Clinical pharmacology and therapeutics. 2004, Vol 75, Num 1, pp 70-79, issn 0009-9236, 10 p.Article

Somatostatin analogs in the treatment of medullary thyroid carcinomaDIEZ, J. J; IGLESIAS, P.Journal of endocrinological investigation (Testo stampato). 2002, Vol 25, Num 9, pp 773-778, issn 0391-4097Article

Antitumour activity of somatostatin analogues in progressive metastatic neuroendocrine tumoursAPARICIO, T; DUCREUX, M; BAUDIN, E et al.European journal of cancer (1990). 2001, Vol 37, Num 8, pp 1014-1019, issn 0959-8049Article

Optimal dosage interval for depot somatostatin analogue therapy in acromegaly requires individual titrationJENKINS, P. J; AKKER, S; CHEW, S. L et al.Clinical endocrinology (Oxford. Print). 2000, Vol 53, Num 6, pp 719-724, issn 0300-0664Article

Traitement médical de l'acromégalie = Drug treatment of acromegalyCORTET-RUDELLI, Christine.MTE. Médecine thérapeutique endocrinologie. 2000, Vol OCT, pp 25-27, issn 1295-9359, NSArticle

Is presurgical treatment with somatostatin analogs necessary in acromegalic patients?LOSA, M; MORTINI, P; GIOVANELLI, M et al.Journal of endocrinological investigation (Testo stampato). 1999, Vol 22, Num 11, pp 871-873, issn 0391-4097Article

Le lanréotide à libération prolongée peut-il se substituer à l'octréotide dans le traitement du dumping syndrome ? = Can we substitute lanreotide for octreotide in the treatment of severe postgastrectomy dumping syndrome ?BOUCHE, O; SALMON-ETTERSPERGER, L; FREMOND, L et al.Gastroentérologie clinique et biologique. 1997, Vol 21, Num 1, pp 84-85, issn 0399-8320Article

Somatostatin analogs and receptors : Diagnostic and therapeutic applicationsHOFLAND, L. J; LAMBERTS, S. W. J.Cancer treatment and research. 1997, Vol 89, pp 365-382, issn 0927-3042Article